These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35902747)

  • 21. Novel V97G ASAH1 mutation found in Farber disease patients: unique appearance of the disease with an intermediate severity, and marked early involvement of central and peripheral nervous system.
    Chedrawi AK; Al-Hassnan ZN; Al-Muhaizea M; Colak D; Al-Younes B; Albakheet A; Tulba S; Kaya N
    Brain Dev; 2012 May; 34(5):400-4. PubMed ID: 21893389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype.
    Mahmoud IG; Elmonem MA; Zaki MS; Ramadan A; Al-Menabawy NM; El-Gamal A; Mansour L; Issa MY; Abdel-Hamid MS; Abdel-Hady S; Khalifa I; Ibrahim A; Solyom A; Rolfs A; Selim L
    Clin Genet; 2020 Dec; 98(6):598-605. PubMed ID: 32875576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
    Cozma C; Iurașcu MI; Eichler S; Hovakimyan M; Brandau O; Zielke S; Böttcher T; Giese AK; Lukas J; Rolfs A
    Sci Rep; 2017 Jul; 7(1):6149. PubMed ID: 28733637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.
    Dworski S; Lu P; Khan A; Maranda B; Mitchell JJ; Parini R; Di Rocco M; Hugle B; Yoshimitsu M; Magnusson B; Makay B; Arslan N; Guelbert N; Ehlert K; Jarisch A; Gardner-Medwin J; Dagher R; Terreri MT; Lorenco CM; Barillas-Arias L; Tanpaiboon P; Solyom A; Norris JS; He X; Schuchman EH; Levade T; Medin JA
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):386-394. PubMed ID: 27915031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial Medial Calcification through Enhanced small Extracellular Vesicle Release in Smooth Muscle-Specific Asah1 Gene Knockout Mice.
    Bhat OM; Li G; Yuan X; Huang D; Gulbins E; Kukreja RC; Li PL
    Sci Rep; 2020 Feb; 10(1):1645. PubMed ID: 32015399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological manifestations of Farber disease in a new mouse model.
    Beckmann N; Kadow S; Schumacher F; Göthert JR; Kesper S; Draeger A; Schulz-Schaeffer WJ; Wang J; Becker JU; Kramer M; Kühn C; Kleuser B; Becker KA; Gulbins E; Carpinteiro A
    Biol Chem; 2018 Sep; 399(10):1183-1202. PubMed ID: 29908121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency.
    Yu FPS; Dworski S; Medin JA
    Sci Rep; 2018 Jan; 8(1):1808. PubMed ID: 29379059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farber lipogranulomatosis type 1--late presentation and early death in a Croatian boy with a novel homozygous ASAH1 mutation.
    Cvitanovic-Sojat L; Gjergja Juraski R; Sabourdy F; Fensom AH; Fumic K; Paschke E; Levade T
    Eur J Paediatr Neurol; 2011 Mar; 15(2):171-3. PubMed ID: 20609603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of ASAH1-related pure SMA evolving into adult-onset Farber disease.
    Puma A; Ezaru A; Cavalli M; Villa L; Torre F; Biancalana V; Levade T; Grecu N; Sacconi S
    Clin Genet; 2021 Aug; 100(2):234-235. PubMed ID: 34240417
    [No Abstract]   [Full Text] [Related]  

  • 30. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report.
    Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E
    Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.
    Beckmann N; Becker KA; Kadow S; Schumacher F; Kramer M; Kühn C; Schulz-Schaeffer WJ; Edwards MJ; Kleuser B; Gulbins E; Carpinteiro A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency.
    Rybova J; Kuchar L; Sikora J; McKillop WM; Medin JA
    J Inherit Metab Dis; 2022 Nov; 45(6):1175-1190. PubMed ID: 36083604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
    Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
    Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy.
    Schuchman EH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1459-71. PubMed ID: 27155573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinal muscular atrophy associated with progressive myoclonus epilepsy.
    Topaloglu H; Melki J
    Epileptic Disord; 2016 Sep; 18(S2):128-134. PubMed ID: 27647482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.
    Li CM; Park JH; Simonaro CM; He X; Gordon RE; Friedman AH; Ehleiter D; Paris F; Manova K; Hepbildikler S; Fuks Z; Sandhoff K; Kolesnick R; Schuchman EH
    Genomics; 2002 Feb; 79(2):218-24. PubMed ID: 11829492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case report of childhood Farber's disease and literature review].
    Bao XH; Tian JM; Ji TY; Chang XZ
    Zhonghua Er Ke Za Zhi; 2017 Jan; 55(1):54-58. PubMed ID: 28072961
    [No Abstract]   [Full Text] [Related]  

  • 38. The molecular medicine of acid ceramidase.
    Frohbergh M; He X; Schuchman EH
    Biol Chem; 2015 Jun; 396(6-7):759-65. PubMed ID: 25938220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation leads to biochemical and functional correction in two mouse models of acid ceramidase deficiency.
    Rybova J; Sundararajan T; Kuchar L; Dlugi TA; Ruzicka P; McKillop WM; Medin JA
    Mol Ther; 2024 Aug; ():. PubMed ID: 39108096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brief Report: Peripheral Osteolysis in Adults Linked to ASAH1 (Acid Ceramidase) Mutations: A New Presentation of Farber's Disease.
    Bonafé L; Kariminejad A; Li J; Royer-Bertrand B; Garcia V; Mahdavi S; Bozorgmehr B; Lachman RL; Mittaz-Crettol L; Campos-Xavier B; Nampoothiri S; Unger S; Rivolta C; Levade T; Superti-Furga A
    Arthritis Rheumatol; 2016 Sep; 68(9):2323-7. PubMed ID: 26945816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.